Effects of methylphenidate on whirler mice: an animal model for hyperkinesis

Life Sciences
|August 5, 1985
PubMed

Insights

The whirler mouse, a model for hyperkinesis, showed decreased circling activity with methylphenidate. This effect was reversible, suggesting potential for drug screening in hyperkinetic disorders.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Animal Models

Background:

  • The whirler mouse exhibits neurological and behavioral symptoms analogous to hyperkinesis in children.
  • These symptoms include restlessness, excitability, and characteristic rotation behavior.

Purpose of the Study:

  • To evaluate the efficacy of methylphenidate in the whirler mouse model of hyperkinesis.
  • To determine the potential of this animal model for screening hyperkinesis treatments.

Main Methods:

  • Oral administration of methylphenidate (5.0 mg/kg daily) to whirler mice for 23 weeks.
  • Assessment of circling activity and reversibility of effects after drug cessation.
  • Administration of a single dose (2.5 mg/kg) after prolonged cessation.

Main Results:

  • Chronic methylphenidate administration significantly reduced circling behavior in whirler mice.
  • The reduction in circling activity was reversible upon cessation of the drug.
  • A single dose after 18 weeks of cessation showed a non-significant increase in circling.

Conclusions:

  • Methylphenidate paradoxically decreased hyperactivity in the whirler mouse model.
  • The whirler mouse is a potentially valuable model for screening drugs targeting hyperkinesis.
  • Reversibility of effects supports its utility in studying stimulant medication dynamics.

Related Concept Videos